# OnCo record izabright-breast01 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/izabright-breast01/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "izabright-breast01", "NCT06926868" ;
  schema:name "IZABRIGHT-Breast01"@en ;
  schema:description "IZABRIGHT-Breast01 is the global first-line trial of the EGFR×HER3 bispecific ADC in triple-negative breast cancer."@en ;
  schema:url <https://onco.cc/trials/izabright-breast01/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06926868> ;
  onco:status "recruiting" ;
  onco:phase "2/3" ;
  schema:startDate "2025-09-11" ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/bispecific-adc/> ;
  onco:drugs <https://onco.cc/drugs/izalontamab-brengitecan/> .